Testosterone undecanoate - Lipocine

Drug Profile

Testosterone undecanoate - Lipocine

Alternative Names: LPCN-1111

Latest Information Update: 20 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lipocine
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Hypogonadism

Most Recent Events

  • 20 Mar 2017 Phase-II development is ongoing in USA (PO)
  • 26 Sep 2016 Lipocine completes a phase IIb trial for Hypogonadism in USA
  • 26 Sep 2016 Adverse events data from a phase IIb trial in Hypogonadism released by Lipocine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top